Cargando…

Identification of approved and investigational drugs that inhibit hypoxia-inducible factor-1 signaling

One of the requirements for tumor development is blood supply, most often driven by hypoxia-induced angiogenesis. Hypoxia induces the stabilization of hypoxia-inducible factor-1 alpha (HIF-1α), which induces expression of an angiogenic factor, vascular endothelial growth factor (VEGF). The purpose o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Chia-Wen, Huang, Ruili, Khuc, Thai, Shou, David, Bullock, Joshua, Grooby, Suzanne, Griffin, Sue, Zou, Chaozhong, Little, Annette, Astley, Holly, Xia, Menghang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884984/ https://www.ncbi.nlm.nih.gov/pubmed/26882567 http://dx.doi.org/10.18632/oncotarget.6995

Ejemplares similares

Identification of Angiogenesis Inhibitors Using a Co-culture Cell Model in a High-Content and High-Throughput Screening Platform
por: Li, Shuaizhang, et al.
Publicado: (2017)

Multiple Metabolic Alterations Exist in Mutant PI3K Cancers, but Only Glucose Is Essential as a Nutrient Source
por: Foster, Rebecca, et al.
Publicado: (2012)

Mechanism Profiling of Hepatotoxicity Caused by Oxidative Stress Using Antioxidant Response Element Reporter Gene Assay Models and Big Data
por: Kim, Marlene Thai, et al.
Publicado: (2015)

Use of Tox21 Screening Data to Evaluate the COVID-19 Drug Candidates for Their Potential Toxic Effects and Related Pathways
por: Sakamuru, Srilatha, et al.
Publicado: (2022)

Quantitative High-Throughput Profiling of Environmental Chemicals and Drugs that Modulate Farnesoid X Receptor
por: Hsu, Chia-Wen, et al.
Publicado: (2014)

Investigating the landscape of US orphan product approvals
por: Miller, Kathleen L., et al.
Publicado: (2018)

China approves first gene therapy
por: Pearson, Sue, et al.
Publicado: (2004)

Performance of the BG1Luc ER TA Method in a qHTS Format
por: Ceger, Patricia, et al.
Publicado: (2015)

Ethics review as a component of institutional approval for a multicentre continuous quality improvement project: the investigator's perspective
por: Ezzat, Hanna, et al.
Publicado: (2010)

Dostarlimab: From preclinical investigation to drug approval and future directions
por: Cicala, Carlo Maria, et al.
Publicado: (2023)

Repurposing drugs as COVID-19 therapies: A toxicity evaluation
por: Ngan, Deborah K., et al.
Publicado: (2022)

Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
por: Lemery, Steven, et al.
Publicado: (2022)

High-Throughput Chemical Screening and Structure-Based Models to Predict hERG Inhibition
por: Krishna, Shagun, et al.
Publicado: (2022)

Approved Nanomedicine against Diseases
por: Jia, Yuanchao, et al.
Publicado: (2023)

Recently Approved and Under Investigation Drugs for Treating Patients with Heart Failure
por: Castro-Torres, Yaniel, et al.
Publicado: (2020)

Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease
por: Di Luca, Daniel Garbin, et al.
Publicado: (2022)

Approved and investigational fluorescent optical imaging agents for disease detection in surgery
por: Rehman, Sonia, et al.
Publicado: (2023)

Investigating Glioblastoma Response to Hypoxia
por: Chédeville, Agathe L., et al.
Publicado: (2020)

A Cell-Based β-Lactamase Reporter Gene Assay for the CREB Signaling Pathway
por: Xia, Menghang, et al.
Publicado: (2009)

Prescribed but not approved: biologic agents used without approval in juvenile idiopathic arthritis in Switzerland, France and Belgium
por: Woerner, Andreas, et al.
Publicado: (2014)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

Patient advocacy organizations’ information for patients on pre-approval access to investigational treatments
por: Folkers, Kelly McBride, et al.
Publicado: (2019)

Investigating the Food and Drug Administration Biotherapeutics Review and Approval Process: Narrative Review
por: Bonet Olivencia, Samuel, et al.
Publicado: (2021)

Winning approval
por: Schopper, Herwig Franz
Publicado: (2004)

Approved Minutes
Publicado: (2010)

Approved Minutes
Publicado: (2010)

Approved Minutes
Publicado: (2011)

Approved Minutes
Publicado: (2009)

Approved Minutes
Publicado: (2008)

Approval voting
por: Brams, Steven J, et al.
Publicado: (2007)

Ethics Approval
por: Ross, W M
Publicado: (1994)

Approved Criminality
por: Consley, J. M.
Publicado: (1892)

MON-032 Identification of Estrogen-Related Receptor Alpha Inhibitors from the Tox21 10K Compound Collection
por: Lynch, Caitlin, et al.
Publicado: (2019)

Seek success, not approval: the only approval you need is yours
por: Elko, Kevin, et al.
Publicado: (2010)

Surface Phosphatidylserine Is Responsible for the Internalization on Microvesicles Derived from Hypoxia-Induced Human Bone Marrow Mesenchymal Stem Cells into Human Endothelial Cells
por: Wei, Xiaojuan, et al.
Publicado: (2016)

Two High Throughput Screen Assays for Measurement of TNF-α in THP-1 Cells
por: Leister, Kristin P, et al.
Publicado: (2011)

Bioactivity Signatures of Drugs vs. Environmental Chemicals Revealed by Tox21 High-Throughput Screening Assays
por: Ngan, Deborah K., et al.
Publicado: (2019)

A gene expression biomarker for predictive toxicology to identify chemical modulators of NF-κB
por: Korunes, Katharine L., et al.
Publicado: (2022)

Approval of a Project for Private Donor Funding and List of Approved Projects
Publicado: (2018)

Quality evaluation of investigator‐initiated trials using post‐approval cancer drugs in Japan
por: Kondo, Shunsuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6n0m57v5j5kr2drle834cfl4tu